Attys Get $2.5M In $7.5M Preterm-Birth Drug Settlement
By Mike Curley · January 28, 2026, 6:09 PM EST
A New Jersey federal judge has given final approval to a $7.5 million settlement to end claims that AMAG Pharmaceuticals Inc. knew its preterm-birth prevention drug Makena was ineffective when it...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login